PubRank

Synergic Effects of Physical Activity and Probiotic on Gut Immune System and Quality of Life of Breast Cancer Survivors. (ESICA)

Clinical Trial ID NCT03760653

PubWeight™ 0.00‹?›

🔗 Visit the ClinicalTrials.gov page for NCT03760653

Top papers

Rank Title Journal Year PubWeight™‹?›
1 UniFrac: a new phylogenetic method for comparing microbial communities. Appl Environ Microbiol 2005 49.76
2 Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2014 40.30
3 The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993 38.99
4 American College of Sports Medicine roundtable on exercise guidelines for cancer survivors. Med Sci Sports Exerc 2010 6.18
5 Physical activity for cancer survivors: meta-analysis of randomised controlled trials. BMJ 2012 4.19
6 Exercise for the management of cancer-related fatigue in adults. Cochrane Database Syst Rev 2012 3.26
7 Reliability and validity of the International Physical Activity Questionnaire (IPAQ). Med Sci Sports Exerc 2004 2.26
8 The role of intestinal microbiota in the development and severity of chemotherapy-induced mucositis. PLoS Pathog 2010 1.77
9 Innate immune inflammatory response against enteric bacteria Helicobacter hepaticus induces mammary adenocarcinoma in mice. Cancer Res 2006 1.68
10 Barriers and facilitators to implementing cancer survivorship care plans. Oncol Nurs Forum 2013 1.18
11 Combined aerobic and resistance training in breast cancer survivors: A randomized, controlled pilot trial. Int J Sports Med 2006 1.16
12 Cancer-related fatigue and its impact on functioning. Cancer 2013 1.05
13 A prospective model of care for breast cancer rehabilitation: function. Cancer 2012 1.02
14 Gut Pharmacomicrobiomics: the tip of an iceberg of complex interactions between drugs and gut-associated microbes. Gut Pathog 2012 1.00
15 Twenty-five years of research on the effects of exercise training in breast cancer survivors: A systematic review of the literature. World J Clin Oncol 2014 0.93
16 Pain in long-term breast cancer survivors: the role of body mass index, physical activity, and sedentary behavior. Breast Cancer Res Treat 2012 0.91
17 Effect of a diet and physical activity intervention on body weight and nutritional patterns in overweight and obese breast cancer survivors. Med Oncol 2013 0.91
18 Gut microbiome and anticancer immune response: really hot Sh*t! Cell Death Differ 2014 0.90
19 Gut bacteria and cancer. Biochim Biophys Acta 2015 0.84
20 Gut Microbiota Modification: Another Piece in the Puzzle of the Benefits of Physical Exercise in Health? Front Physiol 2016 0.82
21 Investigation of the association between the fecal microbiota and breast cancer in postmenopausal women: a population-based case-control pilot study. J Natl Cancer Inst 2015 0.81
22 Physical activity and sedentary behavior in breast cancer survivors: New insight into activity patterns and potential intervention targets. Gynecol Oncol 2015 0.81
23 Change in quality of life among breast cancer survivors after resistance training: is there an effect of age? J Aging Phys Act 2013 0.79
24 Effects of a multicomponent physical activity behavior change intervention on fatigue, anxiety, and depressive symptomatology in breast cancer survivors: randomized trial. Psychooncology 2016 0.77
25 Is Quality of Life Related to Cardiorespiratory Fitness in Overweight and Obese Breast Cancer Survivors? Women Health 2015 0.76
26 Evidence for adapted physical activity as an effective intervention for upper limb mobility and quality of life in breast cancer survivors. J Phys Act Health 2013 0.76
27 Promoting weight loss through diet and exercise in overweight or obese breast cancer survivors (InForma): study protocol for a randomized controlled trial. Trials 2016 0.75
28 Differences in gut microbiota profile between women with active lifestyle and sedentary women. PLoS One 2017 0.75
29 Intestinal microbiota: unexpected alliance with tumor therapy. Immunotherapy 2014 0.75
Next 100